Latest News
Search News
Doctoral training programme secures future investment from MRC
8th July 2021
A partnership between Queen Mary University of London and the University of Southampton has successfully bid for 45 studentships from the Medical Research Council (MRC), part of UK Research and Innovation (UKRI).
Read more
Study identifies biomarker that could help to diagnose pancreatic cancer
29th June 2021
Researchers from Barts Cancer Institute, Queen Mary University of London, have identified a protein that could be used to aid in the diagnosis of pancreatic cancer. Findings from the new study suggest that a protein called pentraxin 3 may be a specific diagnostic biomarker – or biological measure – for pancreatic cancer, with the ability to differentiate pancreatic cancer from other non-cancerous conditions of the pancreas.
Read more
BCI researcher part of team shortlisted for Cancer Grand Challenges awards
23rd June 2021
Dr Benjamin Werner from Barts Cancer Institute, Queen Mary University of London, is part of an international team that has been selected to share its ideas on how to solve one of cancer’s toughest challenges.
Read more
BCI academic receives prestigious science learning award
17th June 2021
Congratulations to Professor Fran Balkwill from Barts Cancer Institute, Queen Mary University of London, who has been announced as the 2021 winner of the Beetlestone Award, which recognises leadership and legacy in the field of informal science learning.
Read more
Study suggests blood test could guide precision treatment in bladder cancer
16th June 2021
A blood test that can detect tiny amounts of circulating cancer DNA may be able to identify risk of cancer recurrence and guide precision treatment in bladder cancer following surgery, according to a clinical study led by Professor Tom Powles from Barts Cancer Institute at Queen Mary University of London and Barts Health NHS Trust. The findings from the study, published today in Nature, may change our understanding of cancer care following surgery.
Read more
Building a human tumour microenvironment in the lab
15th June 2021
Researchers from Barts Cancer Institute at Queen Mary University of London, led by Professor Fran Balkwill and Dr Oliver Pearce, have built two 3D multi-cellular models of the human tumour microenvironment (TME) in ovarian cancer. The models, which are the first created from the CanBuild project, have revealed novel insights into the role of the TME in cancer progression.
Read more